Data / Form D filings / Sonavex, Inc.
Sonavex, Inc.: Form D filings
Sonavex, Inc., a biotechnology company in Baltimore, MD, filed 8 Form D notices with the SEC between 2015 and 2026. The latest, on July 28, 2026, reports $3.1 million sold of a $15 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2835 O'DONNELL STREET SUITE 200, Baltimore, MD, 21224
- Phone
- (443) 862-2024
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1645892
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | New notice | $15,000,000 | $3,102,995 | $11,897,005 | 5 | Jul 13, 2026 | sec.gov |
| Nov 19, 2024 | Amendment | $15,000,004 | $15,000,004 | 45 | Aug 26, 2021 | sec.gov | |
| Feb 2, 2022 | New notice | $5,000,000 | $2,300,000 | $2,700,000 | 19 | Aug 26, 2021 | sec.gov |
| Nov 1, 2019 | New notice | Indefinite | $1,800,000 | 11 | Oct 11, 2019 | sec.gov | |
| Jan 19, 2017 | Amendment | $4,250,000 | $2,207,069 | $2,042,931 | 12 | Aug 4, 2016 | sec.gov |
| Aug 18, 2016 | New notice | $2,750,000 | $2,042,069 | $707,931 | 10 | Aug 4, 2016 | sec.gov |
| Oct 20, 2015 | New notice | $320,192 | $320,192 | 6 | Oct 14, 2015 | sec.gov | |
| Jun 29, 2015 | New notice | $400,000 | $70,000 | $330,000 | 2 | May 4, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Narrow | Executive Officer, Director | |
| Devin O'Brien-Coon | Director | |
| Alex Yevzlin | Executive Officer | |
| William Niland | Director | |
| Robert Hallenbeck | Director | |
| Evan Pritchard | Director | |
| Michael J. Hennessy, Jr. | Director |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of Jul 27, 2026 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Sonavex, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.